Evidence map›Paper›PMID 39559898›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Marmosets as model systems for the study of Alzheimer's disease and related dementias: Substantiation of physiological tau 3R and 4R isoform expression and phosphorylation.

Hasi Huhe, Sarah M Shapley, Duc M Duong, Fang Wu, Seung-Kwon Ha, Sang-Ho Choi, Julia Kofler, Yongshan Mou, Thais Rafael Guimaraes, Amantha Thathiah and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Hasi HuheAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Sarah M ShapleyDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-3002-8664
Duc M DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Fang WuDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Seung-Kwon HaDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Sang-Ho ChoiDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Julia KoflerDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Yongshan MouDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Thais Rafael GuimaraesDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Amantha ThathiahDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Caroline M WatsonDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Lauren K H SchaefferDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Gregory W CarterThe Jackson Laboratory, Bar Harbor, Maine, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Afonso C SilvaDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Stacey J Sukoff RizzoAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Funding

Veterinary and Colony Management CoreU19AG074866 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Stacey J Rizzo · 2022 to 2026
$44.9M
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau SeedingR24AG073190 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SILVA, AFONSO C · 2021 to 2024
$4.5M
NIA NIH HHS R24 AG073190NIA NIH HHS R24AG073190NIA NIH HHS U19 AG074866NIH HHS U19AG074866
6 · The paper itself

Abstract

introductionMarmosets spontaneously develop pathological hallmarks of Alzheimer's disease (AD) including amyloid beta plaques. However, tau expression in the marmoset brain has been understudied.

methodsIsoforms of tau were examined by western blot, mass spectrometry, immunofluorescence, and immunohistochemical staining.

results3R and 4R tau isoforms are expressed in marmoset brains at both the transcript and protein levels across ages. Mass spectrometry analysis revealed that tau peptides in marmoset corresponded to the 3R and 4R peptides in human brain, with 3R predominating at birth and an ≈40%:60% 3R:4R ratios in adolescents and adults; tau was distributed widely in neurons, with localization in the soma and synaptic regions. Phosphorylation residues were observed on Threonine (Thr) Thr181, Thr217, Thr231, Serine (Ser) Ser202/Thr205, and Ser396/Ser404. DISCUSSION: Our results confirm both 3R and 4R tau isoform expression and phosphorylation residues in the marmoset brain, and emphasize the significance of marmosets with natural expression of AD-related hallmarks as important translational models for AD. Highlights We report comprehensive characterization of tau isoform expression in marmoset brains across the lifespan. 3R and 4R tau isoforms are expressed in marmoset brains at both the transcript and protein levels across ages. These data emphasize the significance of marmosets with natural expression of primate-specific traits that are important for the study of Alzheimer's disease.

Indexed as

Alzheimer DiseaseBraintau ProteinsAnimalsCallithrixDisease Models, AnimalFemaleHumansMalePhosphorylationProtein IsoformsProtein Isoformstau ProteinsAlzheimer's diseasebiomarkersmarmosetstau

Identifiers

PMID39559898
PMCPMC11782843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.